Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $62.00 → $65.00 | Market Perform → Outperform | BMO Capital Markets |
| 8/7/2024 | $58.00 | Market Perform → Market Outperform | CJS Securities |
| 4/22/2024 | $52.00 → $62.00 | Hold → Buy | Jefferies |
| 11/6/2023 | $49.00 | Market Outperform → Market Perform | CJS Securities |
| 10/3/2023 | $62.00 → $53.00 | Buy → Hold | Loop Capital |
| 8/7/2023 | $71.00 → $60.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/27/2023 | $64.00 → $75.00 | Hold → Buy | Loop Capital |
| 5/5/2023 | $92.00 → $64.00 | Buy → Hold | Loop Capital |
4 - Ingevity Corp (0001653477) (Issuer)
Ingevity Corporation (NYSE:NGVT) announced today that it will release its first quarter 2026 earnings after the stock market close on Wednesday, May 6, 2026. The company will host a live webcast on Thursday, May 7, at 10:00 a.m. (Eastern) to discuss first quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 616645588. Callers outside the U.S. can find international dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (
Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior
GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with management teams, available upon request. For those who cannot attend in person, access to the symposium will be available via webcast. Investors should contact their Gabelli relations
8-K - Ingevity Corp (0001653477) (Filer)
SCHEDULE 13G/A - Ingevity Corp (0001653477) (Subject)
DEFA14A - Ingevity Corp (0001653477) (Filer)
BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously
CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00
Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
Ingevity Corporation (NYSE:NGVT) announced today that it will release its first quarter 2026 earnings after the stock market close on Wednesday, May 6, 2026. The company will host a live webcast on Thursday, May 7, at 10:00 a.m. (Eastern) to discuss first quarter 2026 fiscal results. Registration for the webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 461 5787 (inside the U.S.) and entering access code 616645588. Callers outside the U.S. can find international dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (
Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior
Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, at 10:00 a.m. (Eastern) to discuss fourth quarter and full year 2025 fiscal results. The webcast can be accessed via the investors section of Ingevity's website. Participants may pre-register for the event here. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 102386. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recordin
Ingevity Corporation (NYSE:NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief financial officer transition Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity's financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expan
Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president. Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven abili
Ingevity Corporation (NYSE:NGVT) today announced Ed Woodcock, executive vice president and president, Performance Materials, departed the company effective July 1, 2025. Woodcock's departure follows a 37-year career with the company. "Ed Woodcock's leadership has been foundational to the successful growth of Ingevity's Performance Materials activated carbon business as the industry leader in automotive emissions capture," said Ingevity president and CEO, Dave Li. "During his extensive career with the company, Ed drove global expansion of the business, delivered consistently strong profitability and positioned the Performance Materials segment for growth in the hybrid and electric vehicle
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13D/A - Ingevity Corp (0001653477) (Subject)